These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35692508)

  • 1. An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty.
    Shiri M; Ahmadizar F
    J Ambient Intell Humaniz Comput; 2022 Jun; ():1-25. PubMed ID: 35692508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing a testing kit supply network for suspected COVID-19 cases under mixed uncertainty approach.
    Hosseini-Motlagh SM; Samani MRG; Farokhnejad P
    Appl Soft Comput; 2021 Nov; 111():107696. PubMed ID: 34305490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing an optimization model for the vaccine supply chain during the COVID-19 pandemic.
    Valizadeh J; Boloukifar S; Soltani S; Jabalbarezi Hookerd E; Fouladi F; Andreevna Rushchtc A; Du B; Shen J
    Expert Syst Appl; 2023 Mar; 214():119009. PubMed ID: 36312907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new vaccine supply chain network under COVID-19 conditions considering system dynamic: Artificial intelligence algorithms.
    Kamran MA; Kia R; Goodarzian F; Ghasemi P
    Socioecon Plann Sci; 2023 Feb; 85():101378. PubMed ID: 35966449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mathematical programming approach for equitable COVID-19 vaccine distribution in developing countries.
    Tavana M; Govindan K; Nasr AK; Heidary MS; Mina H
    Ann Oper Res; 2021 Jun; ():1-34. PubMed ID: 34099948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bi-objective optimization of a stochastic resilient vaccine distribution network in the context of the COVID-19 pandemic.
    Mohammadi M; Dehghan M; Pirayesh A; Dolgui A
    Omega; 2022 Dec; 113():102725. PubMed ID: 35915776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-stage stochastic programming approach to epidemic resource allocation with equity considerations.
    Yin X; Büyüktahtakın IE
    Health Care Manag Sci; 2021 Sep; 24(3):597-622. PubMed ID: 33970390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing a sustainable reverse supply chain network for COVID-19 vaccine waste under uncertainty.
    Amani Bani E; Fallahi A; Varmazyar M; Fathi M
    Comput Ind Eng; 2022 Dec; 174():108808. PubMed ID: 36405560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing a sustainable-resilient-responsive supply chain network considering uncertainty in the COVID-19 era.
    Moadab A; Kordi G; Paydar MM; Divsalar A; Hajiaghaei-Keshteli M
    Expert Syst Appl; 2023 Oct; 227():120334. PubMed ID: 37192999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supply chain planning of vaccine and pharmaceutical clusters under uncertainty: The case of COVID-19.
    Kochakkashani F; Kayvanfar V; Haji A
    Socioecon Plann Sci; 2023 Jun; 87():101602. PubMed ID: 37255585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social equity-based distribution networks design for the COVID-19 vaccine.
    Dastgoshade S; Shafiee M; Klibi W; Shishebori D
    Int J Prod Econ; 2022 Aug; 250():108684. PubMed ID: 36337682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stochastic Inventory Model for Minimizing Blood Shortage and Outdating in a Blood Supply Chain under Supply and Demand Uncertainty.
    Shih H; Rajendran S
    J Healthc Eng; 2020; 2020():8881751. PubMed ID: 32952991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A data-driven optimization model to response to COVID-19 pandemic: a case study.
    Eshkiti A; Sabouhi F; Bozorgi-Amiri A
    Ann Oper Res; 2023 Jun; ():1-50. PubMed ID: 37361061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing a Resilient-Sustainable Supply Chain Network of Age-Differentiated Blood Platelets Using Vertical-Horizontal Transshipment and Grey Wolf Optimizer.
    Shokouhifar M; Goli A
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A robust optimization model for multi-objective blood supply chain network considering scenario analysis under uncertainty: a multi-objective approach.
    Fariman SK; Danesh K; Pourtalebiyan M; Fakhri Z; Motallebi A; Fozooni A
    Sci Rep; 2024 Apr; 14(1):9452. PubMed ID: 38658546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities and effectiveness of COVID-19 vaccine policies in three representative European countries.
    Xie W; Shi L; Liu M; Yang J; Ma M; Sun G
    Int J Equity Health; 2024 Jan; 23(1):16. PubMed ID: 38287322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finding optimal vaccination strategies under parameter uncertainty using stochastic programming.
    Tanner MW; Sattenspiel L; Ntaimo L
    Math Biosci; 2008 Oct; 215(2):144-51. PubMed ID: 18700149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A socio-economic optimization model for blood supply chain network design during the COVID-19 pandemic: An interactive possibilistic programming approach for a real case study.
    Tirkolaee EB; Golpîra H; Javanmardan A; Maihami R
    Socioecon Plann Sci; 2023 Feb; 85():101439. PubMed ID: 36164508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supply chains create global benefits from improved vaccine accessibility.
    Wang D; Bjørnstad ON; Lei T; Sun Y; Huo J; Hao Q; Zeng Z; Zhu S; Hallegatte S; Li R; Guan D; Stenseth NC
    Nat Commun; 2023 Mar; 14(1):1569. PubMed ID: 36944651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A robust optimization problem for drone-based equitable pandemic vaccine distribution with uncertain supply.
    Wang X; Jiang R; Qi M
    Omega; 2023 Sep; 119():102872. PubMed ID: 37020741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.